Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.

At Illumina, we have the opportunity to do work that transforms human health. Find genomics and biotech jobs at Illumina.

Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.

View a complete list of Illumina sequencing and microarray products. Filter by system compatibility and other key features to narrow the list.

4 days ago · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome.

Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

Apr 3, 2023 · Illumina, a global leader in DNA sequencing and array-based technologies, celebrates its 25th year in business. For our anniversary, we’re counting the ways our technology has changed health care and the environment

6 days ago · Shares of Illumina sank 6% and are down 12% over the last year. UPDATE—This story has been updated with company statements and the latest share price information.